Prosecution Insights
Last updated: April 19, 2026

Wuhan Humanwell Innovative Drug Research And Development Center Limited Company

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18264424 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF TOWNSLEY, SARA ELIZABETH 1629 Non-Final OA Aug 06, 2023
18034793 CD73 INHIBITOR AND USE THEREOF ISMAIL, REHANA 1625 Non-Final OA May 01, 2023
18127160 BENZAMIDE COMPOUND AND USE THEREOF HEITMEIER, KENDALL NICOLE 1621 Non-Final OA Mar 28, 2023

Managing Wuhan Humanwell Innovative Drug Research And Development Center Limited Company's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month